FTC Drops Hammer On Warner Chilcott

Law360, New York (October 26, 2006, 12:00 AM EDT) -- In a blow to Warner Chilcott Ltd., the Federal Trade Commission has forbidden the pharmaceutical giant from entering into pacts where generic drug makers agree not to compete with its products, part of the recently brokered settlement over blockbuster birth control drug Ovcon 35.

The terms of the deal came to light on Wednesday, with the FTC revealing the various restrictions it had placed upon the Bermuda-based specialty pharmaceutical company.

On Friday, Warner Chilcott Ltd. agreed to settle the antitrust lawsuit brought last year by the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.